The disclosed method provides a direct method for creating immunological memory against HIV by educating a patient's naive T and B lymphocytes in vitro into HIV antigen-specific adaptive immune memory lymphocytes. Said memory lymphocytes which were created in vitro undergo process wherein memory B lymphocytes are genetically modified for broadly neutralizing antibodies, as well as repeatedly stimulated with HIV antigens. Memory T lymphocytes undergo gene editing for chemokine receptors used by HIV for infection. Said memory lymphocytes are administered to said patient with an immunological memory against HIV in a solution which does not contain chemicals that are opposed to anti-vaccine supporters.